Compound Detail
CHEMBL488853
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL488853 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WREOYWLJBIHNSG-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
506.6
MW (Da)
4.84
ALogP
10
HBA
6
HBD
174.0
PSA (Ų)
0.11
QED
2
Ro5 Violations
15
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 5.34
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 5.34 | 5.34 | 4600.0 | 1 |
| Hepatitis C virus CHEMBL379 | EC50 | 5.19 | 5.19 | 6500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus 1 | EC50 | = | 4600.0 | nM | 5.34 | Antiviral activity against HIV1 3B infected in human CEM cells assessed as reduc... | 25617695 |
| Hepatitis C virus | EC50 | = | 6500.0 | nM | 5.19 | Antiviral activity against HCV genotype 1b I389luc-ubi-neo/NS3-3'/5.1 replicons ... | 25617695 |
Literature References
Data from ChEMBL 36 via Core Engine